Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
Clinical trial NCT07096609 · RECRUITING
Trial details
- NCT number
- NCT07096609
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-29
- Primary completion
- 2027-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.